Serenus Biotherapeutics
Privately held specialty biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
€156—235m (Dealroom.co estimates Mar 2015.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$43.0m | Late VC | ||
Total Funding | €39.1m |
Recent News about Serenus Biotherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.